Lamiaa Hamie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lamiaa Hamie has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Mazen Kurban
Department of Dermatology American University of Beirut Medical Center Beirut Lebanon
6 shared publications - Ossama Abbas
Department of Dermatology American University of Beirut Medical Center Beirut Lebanon
6 shared publications Ossama Abbas
Department of Dermatology American University of Beirut Medical Center Beirut Lebanon
4 shared publicationsMazen Kurban
Department of Dermatology American University of Beirut Medical Center Beirut Lebanon
3 shared publicationsAssaad Eid
Department of Anatomy, Cell Biology and Physiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
2 shared publicationsChristel Tamer
Department of Radiology, American University of Beirut, Beirut, Lebanon
2 shared publications
Latest Publications
- 11 January 2024
- Published by Wiley in Pediatric Dermatology
- Vol. 41 (2) , 364-365
Effect of clarithromycin in a case of infantile bullous pemphigoid
Although rare, cases of infantile or childhood bullous pemphigoid are increasingly being reported in the literature. Treatment challenges, which are amplified in infancy, necessitate balancing efficacy and avoiding long‐term risks. In this report, clarithromycin was successfully used to establish and maintain disease remission, offering insights into its immunomodulatory effects, making it a compelling steroid‐sparing choice with a favorable side effect profile.
- 11 January 2024
- Published by Wiley in Pediatric Dermatology
- Vol. 41 (2) , 364-365
Effect of clarithromycin in a case of infantile bullous pemphigoid
Although rare, cases of infantile or childhood bullous pemphigoid are increasingly being reported in the literature. Treatment challenges, which are amplified in infancy, necessitate balancing efficacy and avoiding long‐term risks. In this report, clarithromycin was successfully used to establish and maintain disease remission, offering insights into its immunomodulatory effects, making it a compelling steroid‐sparing choice with a favorable side effect profile.
- 12 August 2022
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 23 (6) , 853-867
Treatments for Non-Syndromic Inherited Ichthyosis, Including Emergent Pathogenesis-Related Therapy
The term ‘inherited ichthyosis’ refers to a heterogeneous group of mendelian disorders of cornification that involve the integument with varying degrees of scaling. The management of ichthyosis poses a challenge for most physicians. Treatment options proposed in the literature include moisturizers, topical keratolytics, topical and systemic vitamin D analogues, and topical and systemic retinoids; however, some of these modalities are less reliable than others. Despite the therapeutic impasse imposed by the options above, the emergence of pathogenesis-based treatments along with novel gene therapies appear promising and hold the potential to halt or even revert disorders that arise from single genetic mutations, although research is still quite lacking in this domain. Hence, this review aims to highlight the various treatment modalities available for the management of the cutaneous manifestations of non-syndromic inherited ichthyosis, with an added emphasis on pathogenesis-targeted therapies.
- 12 August 2022
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 23 (6) , 853-867
Treatments for Non-Syndromic Inherited Ichthyosis, Including Emergent Pathogenesis-Related Therapy
The term ‘inherited ichthyosis’ refers to a heterogeneous group of mendelian disorders of cornification that involve the integument with varying degrees of scaling. The management of ichthyosis poses a challenge for most physicians. Treatment options proposed in the literature include moisturizers, topical keratolytics, topical and systemic vitamin D analogues, and topical and systemic retinoids; however, some of these modalities are less reliable than others. Despite the therapeutic impasse imposed by the options above, the emergence of pathogenesis-based treatments along with novel gene therapies appear promising and hold the potential to halt or even revert disorders that arise from single genetic mutations, although research is still quite lacking in this domain. Hence, this review aims to highlight the various treatment modalities available for the management of the cutaneous manifestations of non-syndromic inherited ichthyosis, with an added emphasis on pathogenesis-targeted therapies.
- Open Access
- 5 August 2022
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Molecular Case Studies
- Vol. 8 (5)
A novel pathogenic CDH3 variant underlying heredity hypotrichosis simplex detected by whole-exome sequencing (WES)—a case report
Heredity hypotrichosis simplex (HHS) is a rare nonsyndromic disease form of hypotrichosis simplex (HS) characterized by progressive hair follicle (HF) miniaturization. It is usually inherited in an autosomal dominant manner. The differential diagnosis of HHS and the treatments remain challenging despite recent advancement. In this report, we describe a 19-yr-old female affected with HHS alongside most of her family members. Whole-exome sequencing (WES) was performed for some of the family members to unravel the culprit gene involved in HHS phenotype and ascertain the dermatological examination that was done to classify the phenotypes of the disease. A novel pathogenic variant in the CDH3 gene (p.Ser223GlyfsTer4) was identified as a plausible disease-causing variant for HHS. This is the first report to associate CDH3 variants with a HHS phenotype without macular degeneration using WES. WES is an important tool for genotype–phenotype correlation, precision in diagnosis, and in-depth understanding of the disease mechanisms, leading to possible novel therapeutic targets treatment and better patient outcomes.
- 5 August 2022
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Molecular Case Studies
- Vol. 8 (5)
Open AccessA novel pathogenic CDH3 variant underlying heredity hypotrichosis simplex detected by whole-exome sequencing (WES)—a case report
Heredity hypotrichosis simplex (HHS) is a rare nonsyndromic disease form of hypotrichosis simplex (HS) characterized by progressive hair follicle (HF) miniaturization. It is usually inherited in an autosomal dominant manner. The differential diagnosis of HHS and the treatments remain challenging despite recent advancement. In this report, we describe a 19-yr-old female affected with HHS alongside most of her family members. Whole-exome sequencing (WES) was performed for some of the family members to unravel the culprit gene involved in HHS phenotype and ascertain the dermatological examination that was done to classify the phenotypes of the disease. A novel pathogenic variant in the CDH3 gene (p.Ser223GlyfsTer4) was identified as a plausible disease-causing variant for HHS. This is the first report to associate CDH3 variants with a HHS phenotype without macular degeneration using WES. WES is an important tool for genotype–phenotype correlation, precision in diagnosis, and in-depth understanding of the disease mechanisms, leading to possible novel therapeutic targets treatment and better patient outcomes.
- 4 February 2022
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 49 (4) , 544-545
Erythema induratum of Bazin after intravesical Bacillus Calmette‐Guérin immunotherapy
- 4 February 2022
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 49 (4) , 544-545
Erythema induratum of Bazin after intravesical Bacillus Calmette‐Guérin immunotherapy
- 1 February 2022
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 44 (2) , 153-154
Nonhealing Oral Ulcer in a Child: Answer
- 1 February 2022
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 44 (2) , 153-154
Nonhealing Oral Ulcer in a Child: Answer
- 1 February 2022
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 44 (2) , e18
Nonhealing Oral Ulcer in a Child: Challenge
- 1 February 2022
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 44 (2) , e18
Nonhealing Oral Ulcer in a Child: Challenge
- 23 November 2021
- Published by Wiley in International Journal of Dermatology
- Vol. 61 (11) , 1359-1363
Eosinophilic ulcer of the oral mucosa: An update on clinicopathologic features, pathogenesis, and management
Eosinophilic ulcer of the oral mucosa is a benign, reactive, self‐limited lesion. Its pathogenesis is unclear, and it clinically manifests as a punched‐out ulcer with surrounding indurated border, raising suspicion for a possible malignancy. On histology, an acute and chronic dense inflammatory infiltrate can be appreciated, which can extend to the deep underlying tissue (including skeletal muscle). Eosinophils are especially conspicuous on hematoxylin and eosin staining and might play an important role in the development of the ulcer. Removal of possible triggers followed by monitoring and possible biopsy are among the initial recommendations. Most lesions heal spontaneously without the need for intervention. This review aims at assisting dermatologists to easily recognize this entity, avoiding unnecessary interventions and apprehension.
- 23 November 2021
- Published by Wiley in International Journal of Dermatology
- Vol. 61 (11) , 1359-1363
Eosinophilic ulcer of the oral mucosa: An update on clinicopathologic features, pathogenesis, and management
Eosinophilic ulcer of the oral mucosa is a benign, reactive, self‐limited lesion. Its pathogenesis is unclear, and it clinically manifests as a punched‐out ulcer with surrounding indurated border, raising suspicion for a possible malignancy. On histology, an acute and chronic dense inflammatory infiltrate can be appreciated, which can extend to the deep underlying tissue (including skeletal muscle). Eosinophils are especially conspicuous on hematoxylin and eosin staining and might play an important role in the development of the ulcer. Removal of possible triggers followed by monitoring and possible biopsy are among the initial recommendations. Most lesions heal spontaneously without the need for intervention. This review aims at assisting dermatologists to easily recognize this entity, avoiding unnecessary interventions and apprehension.
- 21 July 2021
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 22 (5) , 667-680
Primary Localized Cutaneous Amyloidosis of Keratinocyte Origin: An Update with Emphasis on Atypical Clinical Variants
Amyloid is a protein derived from at least 20 different substances. Once misfolded, it results in a group of cutaneous and systemic conditions. Primary localized cutaneous amyloidosis of keratinocyte origin is a very common subtype that can manifest either as lichen or macular amyloidosis, lacking systemic involvement. Lichen amyloidosis often presents as multiple hyperpigmented papules on the lower extremities whereas macular amyloidosis is classically characterized by dark brown rippled macules on the interscapular area. Review of the literature reveals that in addition to the classical presentation of primary localized cutaneous amyloidosis there exists a plethora of various manifestations that can be grouped into either geographic or morphologic categories. This review provides clinicians with the intimate knowledge of these presentations and summarizes the available treatment modalities.
- 21 July 2021
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 22 (5) , 667-680
Primary Localized Cutaneous Amyloidosis of Keratinocyte Origin: An Update with Emphasis on Atypical Clinical Variants
Amyloid is a protein derived from at least 20 different substances. Once misfolded, it results in a group of cutaneous and systemic conditions. Primary localized cutaneous amyloidosis of keratinocyte origin is a very common subtype that can manifest either as lichen or macular amyloidosis, lacking systemic involvement. Lichen amyloidosis often presents as multiple hyperpigmented papules on the lower extremities whereas macular amyloidosis is classically characterized by dark brown rippled macules on the interscapular area. Review of the literature reveals that in addition to the classical presentation of primary localized cutaneous amyloidosis there exists a plethora of various manifestations that can be grouped into either geographic or morphologic categories. This review provides clinicians with the intimate knowledge of these presentations and summarizes the available treatment modalities.
- 29 April 2021
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 98 (1164) , 799-810
Genodermatoses with behavioural sequelae
Children with genodermatoses are at an increased risk of developing behavioural disorders which may impart lasting damage on the individual and their family members. As such, early recognition of childhood mental health disorders via meticulous history taking, thorough physical examination, and disorder-specific testing is of paramount importance for timely and effective intervention. If carried out properly, prompt psychiatric screening and intervention can effectively mitigate, prevent or even reverse, the psychiatric sequela in question. To that end, this review aims to inform the concerned physician of the manifestations and treatment strategies relevant to the psychological sequelae of genodermatoses.
- 29 April 2021
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 98 (1164) , 799-810
Genodermatoses with behavioural sequelae
Children with genodermatoses are at an increased risk of developing behavioural disorders which may impart lasting damage on the individual and their family members. As such, early recognition of childhood mental health disorders via meticulous history taking, thorough physical examination, and disorder-specific testing is of paramount importance for timely and effective intervention. If carried out properly, prompt psychiatric screening and intervention can effectively mitigate, prevent or even reverse, the psychiatric sequela in question. To that end, this review aims to inform the concerned physician of the manifestations and treatment strategies relevant to the psychological sequelae of genodermatoses.
- 25 March 2021
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 48 (9) , 1298-1299
Imatinib‐induced eruptive nevi
Imatinib mesylate is a tyrosine kinase inhibitor used in the treatment of a variety of oncological conditions. It has been associated with a spectrum of pigmentary cutaneous side effects. Despite the well‐known association of eruptive melanocytic nevi with the use of other tyrosine kinase inhibitors, this phenomenon has not been linked to the administration of imatinib. We present the first case of imatinib‐induced eruptive nevi in an 18‐year‐old patient with acute lymphocytic leukaemia in remission.
- 25 March 2021
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 48 (9) , 1298-1299
Imatinib‐induced eruptive nevi
Imatinib mesylate is a tyrosine kinase inhibitor used in the treatment of a variety of oncological conditions. It has been associated with a spectrum of pigmentary cutaneous side effects. Despite the well‐known association of eruptive melanocytic nevi with the use of other tyrosine kinase inhibitors, this phenomenon has not been linked to the administration of imatinib. We present the first case of imatinib‐induced eruptive nevi in an 18‐year‐old patient with acute lymphocytic leukaemia in remission.